当前位置: 首页 >> 师资队伍 >> 学院教师 >> 制药工程系 >> 正文

戴霞林

讲师、硕导

办公地点:19-202

联系方式:022-60214719

工作邮箱:daixialin@email.tjut.edu.cn

个人简介

天津理工大学化学化工学院讲师,硕士生导师。主要从事药物固体形态包括药物晶型、盐型、共晶等的制备与性质研究,以及离子液体药物和低共熔溶剂载药制剂的开发研究。主持国家自然科学基金青年基金项目和多项横向课题,以第一作者和通讯作者共发表学术论文13篇。

主讲课程

药物分析学(双语),制药工程专业开放实验

学术经历

2011.09-2015.06  南开大学药学专业学习,获学士学位
2015.08-2020.06  中山大学药剂学专业学习,获博士学位
2020.12-至   今  天津理工大学化学化工学院 讲师,硕导

科研项目

1. 国家自然科学基金青年科学基金项目:基于低共熔溶剂的药物共晶合成及其机制研究(22101204),2022.01-2024.12,30万,第一;
2. 国家自然科学基金面上项目:抗肿瘤药-药纳米共晶的可控合成与增溶增效研究(22271220),2023.01-2026.12,54万,第三;
3. 横向课题:甾体激素类药物共晶的固态分析研究,2021.5-2022.5,5万,第一;
4. 横向课题:化合物CMI2109-2盐型筛选,2023.9-2023.11,4.35万,第一;
5. 横向课题:CMI2109-2盐型化合物晶型筛选研究,2023.11-2024.01,4.35万,第一。

代表性论文

1. Xia-Lin Dai, Bo-Wen Pang, Wen-Ting Lv, Jian-Feng Zhen, Lu Gao, Cai-Wen Li, Jing Xiong,* Tong-Bu Lu, Jia-Mei Chen*, Improving the physicochemical and pharmacokinetic properties of olaparib through cocrystallization strategy. Int. J. Pharmaceut. 2023, 647, 123497.
2. Min Zhang,1 Dai-Lin Gu,1 Jian-Feng Zhen, Tong-Bu Lu, Xia-Lin Dai* and Jia-Mei Chen, A novel drug–drug cocrystal of tegafur and myricetin: optimized properties of dissolution and tabletability. CrystEngComm 2023, 25, 6171-6179.
3. Chao Wu, Lu Gao, Jing Xiong, Xia-Lin Dai,* Wei Gao, Tong-Bu Lu, Jia-Mei Chen*, Salts of rucaparib with dicarboxylic acids: synthesis, crystal structures and solubility. CrystEngComm 2022, 24, 7813-7820.
4. Guan-Lan Huang1, Ling Yang1, Bo-Ying Ren, Xin-Yue Lv, Ling-Yi Song, Xia-Lin Dai*, Jia-Mei Chen*, Simultaneously improving the physicochemical and pharmacokinetic properties of vemurafenib through cocrystallization strategy. J. Drug Deliv. Sci. Tec. 2022, 70, 103230.
5. Jun-Long Jia, Xia-Lin Dai,* Hao-Jie Che, Meng-Ting Li, Xiao-Mei Zhuang, Tong-Bu Lu and Jia-Mei Chen,* Cocrystals of regorafenib with dicarboxylic acids: synthesis, characterization and property evaluation. CrystEngComm 2021, 23, 653-662.
6. Jie Wang, Xia-Lin Dai,* Tong-Bu Lu and Jia-Mei Chen,* Temozolomide−hesperetin drug−drug cocrystal with optimized performance in stability, dissolution, and tabletability. Cryst. Growth Des. 2021, 21, 838-846.
7. Bo-Ying Ren, Xia-Lin Dai,* Jie Wang, Chao Wu, Tong-Bu Lu and Jia-Mei Chen*, Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior. CrystEngComm 2021, 23, 5504-5515.
8. Xia-Lin Dai, Jia Yao, Jun-Hui Deng, Yong-Hui Mo, Tong-Bu Lu and Jia-Mei Chen,* Solubility and permeability improvement of allopurinol by cocrystallization. Cryst. Growth Des. 2020, 20, 5160-5168.
9. Xia-Lin Dai, Chao Wu, Jin-Hui Li, Lian-Chao Liu, Xin He, Tong-Bu Lu and Jia-Mei Chen,* Modulating the solubility and pharmacokinetic property of 5-fluorouracil via cocrystals. CrystEngComm 2020, 22, 3670-3682.
10. Xia-Lin Dai, Alexander P. Voronin, Yong-Liang Huang, German L. Perlovich, Xing-Hua Zhao, Tong-Bu Lu and Jia-Mei Chen,* 5-Fluorouracil cocrystals with lipophilic hydroxy-2-naphthoic acids: crystal structures, theoretical computations and permeation studies. Cryst. Growth Des. 2020, 20, 923-933.

专利专著

1、戴霞林,吕文婷,陈嘉媚,一种奥拉帕尼与丙二酸的共晶及其制备方法,专利号202010707895.8。
2、戴霞林,贾军龙,李梦婷,陈嘉媚,一种瑞戈非尼与辛二酸的共晶及其制备方法,专利号202010702741.X。